Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Medical Condition: Non-Small Cell Lung Cancer;Therapeutic area: Diseases [C] - Cancer [C04]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22
PubPharm (38)
1
A study of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A study of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
A study of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab(Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
A STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS STANDARD OF CARE IN PATIENTS WITH LUNG CANCER : A GLOBAL, RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1 + NON-SMALL CELL LUNG CANCER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
A STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS STANDARD OF CARE IN PATIENTS WITH LUNG CANCER : A GLOBAL, RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF REGN2810 (ANTI-PD 1 ANTIBODY) VERSUS PLATINUM BASED CHEMOTHERAPY IN FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC PD L1 + NON-SMALL CELL LUNG CANCER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A study of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Randomized, Phase 3, Open-label Study of Combinations of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer With Tumors Expressing PD-L1 <50%
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
A study of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in patients with lung cancer : A Randomized, Phase 3, Open-label Study of Combinations of REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients with Advanced or Metastatic Non-Small Cell Lung Cancer With Tumors Expressing PD-L1 <50%
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Non-Small Cell Lung Cancer;Therapeutic area: Diseases [C] - Cancer [C04]
Medienart
38
Aufsätze
38
E-Artikel
38
E-Ressourcen
Zeitschriftentitel
38
WHO International Clinical Trials Registry Plat...
Thema
38
610
Medical Condition: Non-Small Cell Lung Cancer;T...
38
Recruitment Status: Authorised-recruitment may ...
38
Study Type: Interventional
32
Phase: Phase 3
6
Phase: Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
18
2020-
20
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
38
Englisch
Haven't found what you're looking for?
Wird geladen...